Find Grant Funding

Who can apply: Eligible applicants include children's hospitals (centers) as defined by section 340E of the PHS Act (Public Law 106-129) or their affiliated university pediatric partners.21 You will demonstrate eligibility according to 340E of the PHS Act (Public Law 106-129). The primary recipient (center that is listed as the grantee of record on the Notice of Award) is one of the five Children’s hospitals or their affiliated university partners. While you, a single entity, must submit the application and accept legal responsibility for managing the project, you must propose to support a network of five (inclusive of your institution) children’s hospitals or their affiliated university pediatric partners that collectively meet the following geographic criteria: • At least one center in a state within both the Delta Regional Authority and Appalachian Regional Commission.22 • At least one such center at a pediatric hospital in each of HRSA's regions V and VII. 23 • At least one such center in HRSA region VIII or X.24 • At least one such center at a pediatric hospital that is a primary National Institutes of Health Clinical and Translational Science Award grantee or a partner that contributes to the budget request of an academic medical center's application at the time of this application. To confirm eligibility, you must include a letter from the institutional authorized organizational representative (AOR) / business official in the application that confirms they meet the criteria based on the National Center for Advancing Translational Sciences Clinical and Translational Science Awards (CTSA) grant and describes the relationship between their institution and the CTSA Hub. Include letters of commitment in and documentation of eligibility from the children’s hospitals or their affiliated university pediatric partners that are proposed members of the Network in Attachment 4 and complete Attachment 6, following the instructions provided in Section IV.2 Project Narrative, subsection vi Attachments. After receiving applications, HRSA will confirm that you meet all of these eligibility criteria prior to your application being submitted for review.

Who can apply: Eligible applicants include any current recipient funded under the HRSA-19-049 Healthy Start Initiative: Eliminating Disparities in Perinatal Health (start date of April 1, 2019).

Who can apply: States, political subdivisions of states, and Indian tribes and tribal organizations (as defined in section 4 of the Indian Self-Determination and Education Assistance Act (25 U.S.C. § 450b)) not currently funded under HRSA-18-122 and HRSA-19-096 are eligible to apply (i.e., existing recipients of HRSA PMHCA awards or other entities within funded states are not eligible to apply). Please see Appendix for link to currently-funded PMHCA projects.

Who can apply: Current recipients funded under the State Systems Development Initiative Grant Program (HRSA-18-061 and HRSA-18-062) are eligible to apply for supplemental funding under this program.

Who can apply: Entities conducting LEND training programs funded under NOFO HRSA-21-041 (start date of July 1, 2021) are eligible to apply for this competitive supplement.

Who can apply: Eligible applicants include all states and six territories and jurisdictions serving the District of Columbia, Puerto Rico, Guam, the U.S. Virgin Islands, the Commonwealth of the Northern Mariana Islands, and American Samoa. Nonprofit organizations currently funded in FY 2020 under the MIECHV Program are also eligible to apply if the state for which they were funded to provide MIECHV services in FY 2020 does not apply.

Who can apply: Eligible applicants are current recipients that received an initial award under the HRSA-18-063 EMSC State Partnership Program.

Who can apply: Eligible applicants include all current recipients of the Healthy Start Initiative: Eliminating Disparities in Perinatal Health grant (funded under NOFO HRSA-19-049) (start date of April 1, 2019).

Who can apply: Eligible applicants are current recipients who are currently receiving funding under HRSA-20-046 Regional Genetics Network program.